MedTrace Logo

Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction

NCT00871637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-09-07

No results posted yet for this study

Summary

Airway macrophage impairment is a central feature in the immunopathogenesis of chronic obstructive pulmonary disease, regardless of smoking status.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Bronchitis, Chronic
  • Occupational Diseases
  • Tobacco Use Disorder

Sponsors & Collaborators

  • VA Nebraska Western Iowa Health Care System

    collaborator FED

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Jill A Poole, MD · University of Nebraska

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-01
Primary Completion
2009-06-01
Completion
2009-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00871637 on ClinicalTrials.gov